Ackermann R, Ebert T
Urologe A. 1985 May;24(3):150-5.
Until recently radical cystectomy combined with urinary diversion was only justified by most urologists as a therapeutic measure for the management of bladder cancer, when other forms of treatment failed controlling the disease. This attitude was mainly based on a high morbidity and mortality rate of up to 20% of the cases. Improved selection of the patients, progress in improving preoperatively the physical conditions of the patients, intra- and post-operative intensive care and improvement of the surgical technique have contributed considerably to reduce the risks of this procedure. Effective preparation of the small and large bowel, early anticoagulation and digitalis medication as well as an efficient antibiotic treatment starting intraoperatively, and optimal parenteral hyperalimentation are of particular importance. Adjuvant preoperative radiation therapy and a simultaneously performed pelvic lymph node dissection do not contribute to an increased morbidity or mortality rate. Taking into account all available preventive measures, the mortality rate of about 20% 20 years ago has been reduced to about 1-5% at present.
直到最近,大多数泌尿外科医生才认为,当其他治疗方式无法控制膀胱癌病情时,根治性膀胱切除术联合尿流改道术是治疗膀胱癌的合理措施。这种态度主要基于该手术高达20%的病例具有较高的发病率和死亡率。对患者的更好筛选、术前改善患者身体状况方面的进展、术中和术后的重症监护以及手术技术的改进,都在很大程度上有助于降低该手术的风险。对小肠和大肠进行有效的准备、早期抗凝和洋地黄用药,以及术中开始的高效抗生素治疗和最佳的胃肠外营养尤为重要。术前辅助放疗和同时进行的盆腔淋巴结清扫并不会增加发病率或死亡率。考虑到所有可用的预防措施,20年前约20%的死亡率目前已降至约1 - 5%。